chr1-203186754-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001276.4(CHI3L1):c.-131C>G variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.791 in 1,023,164 control chromosomes in the GnomAD database, including 321,325 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as risk factor (no stars).
Frequency
Genomes: 𝑓 0.77 ( 44807 hom., cov: 30)
Exomes 𝑓: 0.79 ( 276518 hom. )
Consequence
CHI3L1
NM_001276.4 upstream_gene
NM_001276.4 upstream_gene
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.968
Genes affected
CHI3L1 (HGNC:1932): (chitinase 3 like 1) Chitinases catalyze the hydrolysis of chitin, which is an abundant glycopolymer found in insect exoskeletons and fungal cell walls. The glycoside hydrolase 18 family of chitinases includes eight human family members. This gene encodes a glycoprotein member of the glycosyl hydrolase 18 family. The protein lacks chitinase activity and is secreted by activated macrophages, chondrocytes, neutrophils and synovial cells. The protein is thought to play a role in the process of inflammation and tissue remodeling. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.825 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHI3L1 | NM_001276.4 | c.-131C>G | upstream_gene_variant | ENST00000255409.8 | NP_001267.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.766 AC: 116321AN: 151856Hom.: 44781 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
116321
AN:
151856
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.795 AC: 692534AN: 871190Hom.: 276518 Cov.: 11 AF XY: 0.796 AC XY: 360982AN XY: 453690 show subpopulations
GnomAD4 exome
AF:
AC:
692534
AN:
871190
Hom.:
Cov.:
11
AF XY:
AC XY:
360982
AN XY:
453690
Gnomad4 AFR exome
AF:
AC:
14824
AN:
21964
Gnomad4 AMR exome
AF:
AC:
34559
AN:
40028
Gnomad4 ASJ exome
AF:
AC:
18660
AN:
21288
Gnomad4 EAS exome
AF:
AC:
31132
AN:
36594
Gnomad4 SAS exome
AF:
AC:
58679
AN:
72634
Gnomad4 FIN exome
AF:
AC:
30562
AN:
41706
Gnomad4 NFE exome
AF:
AC:
467887
AN:
591488
Gnomad4 Remaining exome
AF:
AC:
32398
AN:
40964
Heterozygous variant carriers
0
7181
14361
21542
28722
35903
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
7724
15448
23172
30896
38620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.766 AC: 116398AN: 151974Hom.: 44807 Cov.: 30 AF XY: 0.768 AC XY: 57022AN XY: 74280 show subpopulations
GnomAD4 genome
AF:
AC:
116398
AN:
151974
Hom.:
Cov.:
30
AF XY:
AC XY:
57022
AN XY:
74280
Gnomad4 AFR
AF:
AC:
0.67916
AN:
0.67916
Gnomad4 AMR
AF:
AC:
0.835055
AN:
0.835055
Gnomad4 ASJ
AF:
AC:
0.866282
AN:
0.866282
Gnomad4 EAS
AF:
AC:
0.845483
AN:
0.845483
Gnomad4 SAS
AF:
AC:
0.8047
AN:
0.8047
Gnomad4 FIN
AF:
AC:
0.740383
AN:
0.740383
Gnomad4 NFE
AF:
AC:
0.790051
AN:
0.790051
Gnomad4 OTH
AF:
AC:
0.787405
AN:
0.787405
Heterozygous variant carriers
0
1382
2764
4146
5528
6910
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
856
1712
2568
3424
4280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2759
AN:
3478
ClinVar
Significance: risk factor
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Asthma-related traits, susceptibility to, 7 Other:1
Apr 17, 2008
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at